7. Roots to Sky: Clinical Research & Treatment

7. Roots to Sky: Clinical Research & Treatment

325 bookmarks
Newest
Drug that regrows teeth: A potential breakthrough by 2030
Drug that regrows teeth: A potential breakthrough by 2030
The story of a drug enabling teeth to regrow may sound like a fantasy, but Japanese scientists believe it could soon become a reality. Researchers from Kyoto University Hospital and the University of Fukui are working on this groundbreaking drug. The drug, which could revolutionize the dental industry, might be available by 2030. However, one cruci...
·msn.com·
Drug that regrows teeth: A potential breakthrough by 2030
Study links certain fatty acids in blood to decreased Alzheimer’s risk
Study links certain fatty acids in blood to decreased Alzheimer’s risk
In a significant stride towards understanding Alzheimer’s disease, researchers have discovered that higher levels of certain fatty acids in the blood are associated with a lower risk of brain changes typical of the disease. This finding, published in The Journals of Gerontology: Series A, could pave the way for more effective early detection and ma...
·msn.com·
Study links certain fatty acids in blood to decreased Alzheimer’s risk
Lifestyle changes can reduce dementia risk by maintaining brain plasticity — but the time to act is now
Lifestyle changes can reduce dementia risk by maintaining brain plasticity — but the time to act is now
Walk 10,000 steps a day, cut back alcohol, get better sleep at night, stay socially active — we’re told that changes like these can prevent up to 40 per cent of dementia cases worldwide. Given that dementia is still one of the most feared diseases, why aren’t we pushing our doctors and governments to support these lifestyle changes through new programs and policy initiatives? The truth, however, is more complex. We know that making lifestyle...
·msn.com·
Lifestyle changes can reduce dementia risk by maintaining brain plasticity — but the time to act is now
Shared from Copilot: New advances in type 1 diabetes | The BMJ
Shared from Copilot: New advances in type 1 diabetes | The BMJ
Type 1 diabetes is an autoimmune condition resulting in insulin deficiency and eventual loss of pancreatic β cell function requiring lifelong insulin therapy. Since the discovery of insulin more than 100 years ago, vast advances in treatments have improved care for many people with type 1 diabetes. Ongoing research on the genetics and immunology of type 1 diabetes and on interventions to modify disease course and preserve β cell function have expanded our broad understanding of this condition. Biomarkers of type 1 diabetes are detectable months to years before development of overt disease, and three stages of diabetes are now recognized. The advent of continuous glucose monitoring and the newer automated insulin delivery systems have changed the landscape of type 1 diabetes management and are associated with improved glycated hemoglobin and decreased hypoglycemia. Adjunctive therapies such as sodium glucose cotransporter-1 inhibitors and glucagon-like peptide 1 receptor agonists may find use in management in the future. Despite these rapid advances in the field, people living in under-resourced parts of the world struggle to obtain necessities such as insulin, syringes, and blood glucose monitoring essential for managing this condition. This review covers recent developments in diagnosis and treatment and future directions in the broad field of type 1 diabetes.
·bmj.com·
Shared from Copilot: New advances in type 1 diabetes | The BMJ
Moriarty Lab - Moriarty Lab
Moriarty Lab - Moriarty Lab
[et_pb_section fb_built=”1″ _builder_version=”4.4.3″ background_color=”#000000″ global_colors_info=”{}”][et_pb_row column_structure=”1_6,1_6,1_6,1_6,1_6,1_6″ use_custom_gutter=”on” gutter_width=”1″ make_equal=”on” _builder_version=”4.7.7″ width=”100%” max_width=”100%” global_colors_info=”{}”][et_pb_column type=”1_6″ _builder_version=”4.4.3″ global_colors_info=”{}”][et_pb_image src=”https://35.183.107.192/wp-content/uploads/2016/08/copyGCB72612_512.jpg” title_text=”copyGCB72612_512″ _builder_version=”4.7.7″ global_colors_info=”{}”][/et_pb_image][/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.4.3″ global_colors_info=”{}”][et_pb_image src=”https://35.183.107.192/wp-content/uploads/2016/08/Borrelia-tracking-3-1.jpeg” title_text=”Borrelia tracking 3″ _builder_version=”4.7.7″ global_colors_info=”{}”][/et_pb_image][/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.4.3″ global_colors_info=”{}”][et_pb_image src=”https://35.183.107.192/wp-content/uploads/2016/08/Ursula-Kubes-TransferSnapshot-of-Spirochetes-08.03.07-71.jpg” title_text=”Borrelia interacting with walls of blood vessel in live mouse” _builder_version=”4.7.7″ global_colors_info=”{}”][/et_pb_image][/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.4.3″ global_colors_info=”{}”][et_pb_image src=”https://35.183.107.192/wp-content/uploads/2016/08/CoverFinal-copy-saran-wrap_1k-e1472117022190.jpg” title_text=”CoverFinal copy saran wrap_1k” _builder_version=”4.7.7″ custom_margin=”||||false|false” […]
·moriartylab.org·
Moriarty Lab - Moriarty Lab
Lyme disease: The pathogen's cunning strategies for persistent infection offer clues for vaccine development
Lyme disease: The pathogen's cunning strategies for persistent infection offer clues for vaccine development
Lyme disease is the leading vector-borne disease — meaning diseases that are transmitted to humans from another organism like a tick or mosquito — in North America and Europe. New human cases are estimated at over 400,000 in the United States each year. Canada has experienced a drastic increase in human cases, from 266 cases in 2011 to 3,147 in 2021, as the habitat of its vector, a tick, expands north. The initial symptoms of human Lyme disease...
·msn.com·
Lyme disease: The pathogen's cunning strategies for persistent infection offer clues for vaccine development
Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia | Lifestyle Behaviors | JAMA Neurology | JAMA Network
Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia | Lifestyle Behaviors | JAMA Neurology | JAMA Network
This cohort study examines data from Rush Memory and Aging Project, including autopsy results and up to 24 years of follow-up, to determine the association between lifestyle and cognitive function independently of Alzheimer disease pathology burden.
·jamanetwork.com·
Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia | Lifestyle Behaviors | JAMA Neurology | JAMA Network